Finish Thompson Inc. (FTI), a specialist in the corrosive chemical transfer industry, highlights its SFV drum pump, a cost-effective pump designed for container-to-container transfer of acids, corrosives, and chemicals. Featuring multiple material options and connections,...

CARBOGEN AMCIS has announced that two of its manufacturing sites in Switzerland have passed inspections completed by the U.S. Food and Drug Administration (FDA). The sites in Neuland and Aarau passed with flying colours...

Broken String Biosciences (Broken String) has announced the appointment of its new Chief Commercial Officer, Steve Becker. The newly appointed CCO will help the genomics company strive towards boosting its commercial operations and help implement...

Nine innovative businesses are celebrating receiving 857,000 GBP in funding, from the Innovate UK Biomedical Catalyst feasibility grant, after completing LYVA Labs’ Microbials Accelerator programme – the first Innovate UK programme of its kind in this field. The...

Enterprise Therapeutics (Enterprise) has successfully administered ETD001 to an individual with Cystic Fibrosis. The biopharmaceutical company is focused on developing therapies to help improve the lives of those suffering from respiratory disease. Today’s announcement...

Sirnaomics, a leading biopharmaceutical company engaging in the discovery and development of advanced RNAi therapeutics, announced today that it has completed IND-enabling studies for STP125G, an siRNA therapeutics targeting Apolipoprotein C3 (ApoC3), based on...

PacBio, a leading developer of high-quality, highly accurate sequencing solutions, has announced that Novogene is using its Revio long-read sequencing system to expand the capabilities of its new lab in Munich, Germany, serving customers...

Lario Therapeutics reveals that it has been awarded a $6 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The programme is in collaboration with the Oxford Parkinson’s Disease Centre (OPDC), which...

As the Life Sciences industry comes to depend increasingly on excellent technology and data for speed, efficiency and competitive advantage, it’s more important than ever that companies harness validation as soon as possible in...

Novo Holdings’ portfolio company Invetx is set to be acquired by the international veterinary pharmaceuticals business, Dechra Pharmaceuticals. The deal is said to be up to $520 million in total and will be completed...

The Optimal Group is advancing automated laboratory analysis processes across the pharmaceutical sector with the launch of the SciYbotic Labs range. The new solutions make analysis faster with a higher level of consistency, allowing...

Life sciences manufacturers continuously strive for accelerated launch, increased capacity for in-demand medicine, enhanced security of supply and improved sustainability. The data required to help address these challenges already exists in many cases, provided...

Praxis Packaging Solutions has selected  Systech to provide a track-and-trace platform that aims to improve supply chain transparency. Through the collaboration, Praxis’ customers will have access to high-quality aggregation and enhanced product tracing. Additionally, these features...

Envision Pharma Group (Envision) has launched 4Sight, a new AI and technology-enabled approach designed to help medical affairs teams optimise raw data and turn it into actionable insights for healthcare professionals. 4Sight represents Envision’s...

Building on success of GW pharmaceuticals, the UK has the potential to become the global leader in pharmaceutical cannabinoid R&D, according to a new report published by the Cannabinoid Research and Development Group (CRDG). ...

SPT Labtech’s firefly all-in-one liquid platform has been selected by PRISM BioLab to help the Japanese biotechnology company accelerate the design of small molecule inhibitors of protein-protein interaction targets. The platform will help achieve...

Asceneuron SA, a clinical stage biotech company developing small molecules targeting tau protein aggregation, a root cause of neurodegenerative disease, has announced a 100 million USD oversubscribed Series C financing round to advance the...

Cécile Maupas will be responsible for business development, marketing, project management, commercial operations, and product management....

Commercial director, Rory O’Keeffe, Europlaz, examines the latest innovations that the team believes will be transformative to future clinical pathways. Research recently published by Nova One Advisor indicates that the global point-of-care diagnostics market...

Systech has selected Praxis Packaging Solutions to provide a track-and-trace platform that aims to improve supply chain transparency. Through the collaboration, Praxis’ customers will have access to high-quality aggregation and enhanced product tracing. Additionally,...

Brenntag Specialities Pharma has opened its new Good Manufacturing Practice (GMP) compliant packaging service line. Located in Guntramsdorf, the facility offers repackaging services for clients across Europe with a focus on the pharmaceutical industry....

Upperton Pharma Solutions, a contract development and manufacturing organisation (CDMO), has announced the successful completion of a Medicines and Healthcare products Regulatory Agency (MHRA) inspection at its newly commissioned 50,000 sq ft development and...

Global packaging leader, Berry Global Group, Inc. has introduced a range of special closures and couplings which can be used in conjunction with its popular Politainer combi pack. This provides a closed system that facilitates the...

Mogrify has appointed Dr Jonathan Appleby as its new Chief Scientific Officer. Dr Appleby, who has decades of experience translating both conventional and advanced therapeutic medicines, aims to advance the company’s therapeutic programs, specifically...

Antares Vision Group, a technological partner in the digitalisation of products and supply chains for companies and institutions, has launched DIAMIND Sentry, a solution allowing pharma companies to efficiently manage the uptick in exceptions stemming...

MedPharm, an Ampersand Capital Partners portfolio company, and Tergus Pharma, a Great Point Partners portfolio company, jointly announced a merger. The combined topical and transepithelial Contract Development and Manufacturing Organisation (CDMO) will operate under the MedPharm...

Mini-tabs offer unprecedented flexibility in drug delivery, but not without significant challenges. The pharmaceutical industry is seeing a significant surge in demand for mini-tablets, also known as micro-tablets or mini-tabs. They are an increasingly...

Scenic Biotech has announced the appointment of Ben Machielse to its board of directors. Machielse has over 25 years of experience within the biotech industry, specifically in the development of therapeutics through clinical evaluation...

Envirotainer, a specialist in temperature-sensitive pharmaceutical shipments, has announced significant enhancements to its testing capabilities, with the addition of three new testing chambers. With the capability to test a wider range of temperatures and humidity,...

After the launch of French startup Bioptimus less than five months ago, the company has unveiled its H-optimus-0, which is an open-source AI foundation model for pathology. With 1.1 billion parameters, H-optimus-0 is trained...

Almirall S.A., a global biopharmaceutical company dedicated to medical dermatology, has announced that the National Institute for Health and Care Excellence (NICE) has recommended Ebglyss (lebrikizumab) for use in moderate to severe Atopic Dermatitis...

ChargePoint Technology is expanding its presence in India, and has announced the launch of its new subsidiary, ChargePoint UK Private Ltd.  The subsidiary will focus on business development and providing support services tailored to the...

VectorY Therapeutics, a biotech company developing innovative vectorised antibody therapies for the treatment of neurodegenerative diseases, has announced the appointment of Adam Rosenberg as the new Chair of the Board. Boston-based Mr Rosenberg brings over...

In this episode, you can hear Olivia Friett, editor of Medical Plastics News talk to Scott Nelson, FastWave Medical, about the complete start-up journey – covering the initial idea, looking into ventures, competing with...

Researchers from the Critical Analytics for Manufacturing Personalized-Medicine (CAMP) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, have developed a novel method capable of producing clinical doses of viable...

CPHI South East Asia (10-12th July 2024) returns to Queen Sirikit National Convention Centre in the heart of Bangkok, as the industry undergoes improving prospects driven by increasing pharmaceutical development in the region. Reflecting the...

ILiAD Biotechnologies has selected Emmes Group to conduct the upcoming Phase III clinical trials on its leading pertussis vaccine candidate, BPZE1. Emmes, a global contract research and technology company, were selected for its experience...

NLC Health Ventures, in collaboration with Verily, a precision health technology company, will launch Exolvo Biosciences, a pioneering biotech company delivering the next-generation solution for biologic drug delivery. Through Exolvo, NLC seeks to advance drug delivery...

Aptamer Group plc, the developer of novel Optimer binders to enable innovation in the life sciences industry, has announced a new agreement with AstraZeneca, a global biopharmaceutical company, to evaluate the Optimer fibrotic liver delivery...

CPHI Europe will return to Messe Frankfurt in 2025, scheduled for 28-30th October. The event will bring together the entire supply chain, from ingredients and finished dosages to machinery, bio, packaging, and more. The exhibition...

Torbay Pharma (TP), an independent pharma manufacturer, has announced that CEO, Emma Rooth, has won the Inspiring Change Leader of the Year at the Women in Change Awards. The company says this award signifies the journey...

Discovery Park welcomed experts in healthy ageing to its Innovation Summit on 20th June, calling for the life science network in Kent to join forces to make the county a leader in healthy ageing...

Edinburgh-based 1nhaler has appointed two experts in inhalation and respiratory medicines to the board as it looks to accelerate the development and market-readiness of its single-use inhaler device. Jane Gaddum, formerly vice president for...

A British manufacturing firm has introduced technologies that “promise to revolutionise” drug testing in the medical and pharmaceutical sectors. IPFL’s micro 3D printing services enable the production of intricate three-dimensional structures with previously unachievable...

Almirall S.A., a global pharmaceutical company dedicated to medical dermatology, has launched its new sustainability strategy, Act4Impact 2030.  The updated strategy aims at transforming the company’s sustainability roadmap and focuses on five main pillars: “Planet”, “People”, “Patients”...

With the global injectable pharma market projected to soar to $762.48 billion by 2028, secondary pharmaceutical packaging specialist MM Packaging urges the industry to embrace smart packaging technology for enhanced patient adherence. Walter Wuerfel, VP...

PSG Biotech, a product brand of PSG, has unveiled its new SumoFlo CELE-8103-D Integral Display Transmitter. The pump and flow meter technology provider’s latest launch features a 144×144 mm four-line display, with the transmitter able...

Rhenopharma Group has acquired Konapharma AG, a Swiss contract manufacturer for the pharmaceutical industry. Within the new group of companies, Konapharma now complements the services of packaging company Allpack and Rhenochem, a family-owned company with decades...

Rosemont Pharmaceuticals has acquired Pharma-Data S.A, a privately owned Research and Development Organisation based in Lavrion, Greece. Pharma-Data specialises in Research & Development (R&D) and the development of Value-Added Medicinal Drug Products for Europe and...

Asklepios BioPharmaceutical (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer, has announced initiation of recruitment to REGENERATE-PD, a Phase 2 clinical study assessing efficacy and safety of...

Bio-Rad has extended its anti-biotherapeutic antibodies range to now include anti-idiotypic antibodies for the atezolizumab (Lemtrada), avelumab (Bavencio), obinutuzumab (Gazyvaro), and ocrelizumab (Ocrevus) drugs. Additionally, the life science research and clinical diagnostics product specialist has...

Stability testing is a vital element of ensuring a drug product is compliant with regulatory requirements, irrespective of whether you are submitting to the Food and Drug Administration (FDA), European Medicines Agency (EMA) or...

This GLP-1R / CRE Luciferase Reporter HEK293 cell line has been engineered to monitor activation of GLP-1R in cells by measuring luciferase activity, making it useful for cell-based binding assays and screening for human GLP-1R...

Cytiva has launched its Supor Prime sterilising grade filters to filtrate high-concentration biologic drugs. The latest addition to the life sciences leader’s portfolio aims to help drug developers achieve higher yields, reduce blockages, and...

Thermo Fisher Scientific has introduced the Thermo Scientific KingFisher PlasmidPro Maxi Processor (PlasmidPro), the ‘only’ fully automated maxi-scale plasmid DNA (pDNA) purification system. PlasmidPro enables innovation at scale, providing complete automation across mini and maxi scale purification and...

Labguru (BioData) announces an agreement with Thermo Fisher Scientific to enable the distribution of its Labguru Electronic Lab Notebook (ELN) module alongside Thermo Fisher’s suite of Laboratory Information Management System (LIMS) and lab operations software solutions. With these complementary...

Aurorium, a specialty ingredients manufacturer and materials innovation partner, has announced the launch of Haelium Pharmaceutical Solutions.  “The launch of the Haelium brand will more clearly represent our position in the pharmaceutical space – a...

TurboFil Packaging Machines, an equipment specialist dedicated solely to the design and development of liquid filling and assembly machines, is collaborating with Bridgewater, NJ-based Amneal Pharmaceuticals to develop an advanced automated assembly and vial...

Bora Pharmaceuticals has announced that it has successfully entered into an agreement for Emergent BioSolutions’ sterile manufacturing facility in Baltimore-Camden, Maryland as part of a major commercial expansion for the Company. Bora has an established footprint...

In this episode of The MedTalk Podcast, Olivia Friett the editor of Medical Plastics News, is joined by Adrian Jennings, chief product officer at Cognosos, to discuss how tracking equipment can save hospitals millions....

Discovery Park has opened the doors to CoLab, a new shared lab facility. In partnership with Canterbury Christ Church University, CoLab has been specially designed for early-stage life science businesses, providing flexible bench space in...

Allecra Therapeutics (also known as Allecra) and Acino have signed an exclusive licensing agreement which allows Acino to commercialise the antibiotic drug EXBLIFEP in the Republic of South Africa and members of the GCC alliance. The...

England’s top doctor has backed calls from NHS Blood and Transplant (NHSBT) for O Positive and O Negative blood donors to urgently book appointments to donate in one of the 25 town and city centre...

Regarding the integration of Telstar into Syntegon after an acquisition agreement closed between Azbil Corporation and the German company which has been announced by both firms, Telstar expresses that the company takes a very...

ACG has announced a strategic partnership with EY-Parthenon aiming to enhance ACG’s sustainability initiatives through a comprehensive Net Zero strategy and implementation roadmap aligned with the Science Based Targets initiative (SBTi). Combining ACG’s industry...

Written by: Adriano Leuzzi – Head of Process Development; Angelo Raggioli – Head of Technology Development, ReiThera. The field of gene therapy is witnessing unprecedented growth, offering promising avenues for treating a myriad of diseases,...

Johnson & Johnson Innovative Medicine have announced its strengthened commitment in Italy, with a projected investment of €580 million over the next five years, of which €125 million will support an increase in production capacity...

Written by: Dr Maxim Polyakov, Senior Vice President, Business Intelligence and Research at M3. Pharmaceutical products play in a highly competitive field. Understanding the HCP target audience through market research is vital to ensure pharma companies...

Merck have announced an investment of €62 million at its Darmstadt headquarters in a new quality control building for its Life Science business. The facility will bring together approximately 135 employees across several departments into...

iOnctura have announced that it has closed an €80 million Series B financing. The funding round was led by new investor Syncona Limited with participation by the EIC Fund, the venture arm of the European Innovation...

We caught up with Purolite’s Felix Solamo to look back on Bio International 2024 and what it meant for the Company.  EPM: What new products or innovations did your company showcase at BIO 2024?...

Written by: Niamh Bissett, Director, Operations, PMO, West Pharmaceutical Services. While it officially applies to the manufacture of sterile medicinal products in the European Union, the revised EU Good Manufacturing Practice (GMP) Annex 1 effectively...

Written by: Justin Wilson, partner and pharmaceuticals & gene therapy sector specialist at European intellectual property law firm, Withers & Rogers. Investing in the development of cell and gene therapies (CGTs) for use in the treatment...

Asahi Kasei has announced that in April 2024 it began selling a membrane system to produce WFI (water for injection), a type of sterile water that is used for the preparation of injections. The...

Lyphe Clinic has announced a partnership with Gro-Vida, a licensed medical cannabis cultivar. This collaboration marks a significant step forward in advancing patient care and access to high-quality medical cannabis products within the UK. By forming...

Haier Biomedical has launched the wide neck CryoBio series, a new generation of liquid nitrogen containers offering convenient access to stored samples. This latest addition to the CryoBio range also features an enhanced, intelligent monitoring system that...

Cherwell has introduced a new Redipor Plastic Bottle prepared media range in response to a request from a large pharmaceutical company for support in meeting its sustainability targets. The new terminally sterilised plastic bottled media products have been...

Written by: Dr Sylvain Lacomble, Vice President Europe Middle East & Africa, Terumo Blood and Cell Technologies.  Blood and its components are essential medicines, utilised for a wide range of clinical indications including trauma care,...

UPS Healthcare has announced an expansion of its European hub facility in Roermond, the Netherlands by 21,860 sqm, adding in-demand freezer farm capacity, a crucial link in a strong and reliable supply chain for...

Big pharma behemoths Johnson & Johnson has agreed a payment of $700 million to settle allegations that the Company mislead its customers about the safety of its talc-based products.  This follows an investigation by...

The European Commission’s Health Emergency Preparedness and Response Authority (HERA) as part of its mandate on preparedness, has signed on behalf of participating Member States, a joint procurement framework contract for the supply of...

Laboratory equipment supplier Scientific Laboratory Supplies (SLS) has opened the new SLS National Distribution Centre (NDC) at the Fairham Business Park, Nottingham, as it looks to kickstart its next phase of growth.  The move comes...

Sage Therapeutics announced topline results from the Phase 2 SURVEYOR Study. The study met its primary endpoint demonstrating a statistically significant difference as measured by the HD-Cognitive Assessment Battery (HD-CAB) composite score at baseline between...

Benchling, the R&D Cloud powering the biotech industry, have announced that global pharmaceutical company Sanofi is using Benchling across more than 1,500 scientists from 30 teams.  Benchling is working with Sanofi to transition from legacy R&D...

Cycle Pharmaceuticals a rapidly growing pharmaceutical company focused on treatments for the underserved rare disease patient community, have confirmed that it made a proposal to the Board of Directors of Vanda Pharmaceuticals, Inc on May...

Last week, AstraZeneca announced the successful completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs). The acquisition marks a major step forward in AstraZeneca delivering on its ambition...

Syngene International have announced the launch of its new protein production platform. The platform, using a cell line and transposon-based technology in-licensed from Swiss biotech services company, ExcellGene, coupled with Syngene’s clone selection and development...

Vetter have announced its plans to move and expand its Development Services site from Skokie, Illinois, to Des Plaines, further investing in its U.S. footprint. Simultaneously, the company plans additional major investment in its...

Alchemab Therapeutics has been awarded a grant of $595,000 by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to support its Parkinson’s disease program. The grant will fund research performed at Alchemab following...

Aragen Bioscience and Getinge have announced the successful validation of latter’s Single-Use Production Reactors (SUPR) for large-scale recombinant antibody production. This collaboration combines Aragen’s expertise in biopharmaceutical manufacturing and Getinge’s innovative single-use technology, enabling seamless production...

Nuclera have announced it has been awarded two highly competitive Innovate UK grants totalling £1.14M. The funding, made up of a £790k flexible, agile, scalable, and sustainable technologies (FASST) grant awarded in collaboration with DeepMirror, and...

MediMab Biotherapeutics has opened a new state-of-the-art facility, developed by Kadans Science Partner, at Sovereign House, Abingdon Science Park, UK. The purpose-built building, including state-of-the-art CL2 wet labs, will support the company’s growth and accelerated...

Seres Therapeutics has entered into a non-binding memorandum of understanding with Nestlé Health Science for the sale of Seres’ VOWST assets that will provide Nestlé Health Science with full VOWST product and related intellectual...

Thermo Fisher Scientific has opened a new clinical and commercial ultra-cold facility in the EU, expanding its clinical trial network in Europe to help accelerate the development of advanced therapies. The new current good...

Almac Group, the global contract pharmaceutical development and manufacturing organisation, has announced its financial results for year ending 30 September 2023. Figures released show the company recorded a $93 million rise in revenue to...

Ecolab have announced that its Purolite resin business, together with Repligen Corporation has commercially launched Purolite’s DurA Cycle, a protein A chromatography resin for large-scale purification processes. This new affinity resin is being introduced at...

Ardena have announced the retirement of Harry Christiaens, PhD and the subsequent appointment of Jeremie Trochu as Chief Executive Officer. Jeremie is a seasoned executive in the pharmaceutical Contract Development and Manufacturing Operations (CDMO) industry. Harry...

Bionova Scientific, an Asahi Kasei Group company and full-service biologics CDMO, have announced plans to invest $100 million to expand into plasmid DNA (pDNA) production. The centerpiece of the project is a new 100,000...

Sanofi have completed the acquisition of Inhibrx. The acquisition adds SAR447537 (formerly INBRX-101) to Sanofi’s rare disease pipeline, underscoring the company’s commitment to pursuing differentiated and potential best-in-class medicines that build upon our existing...

DefiniGEN and Atelerix have announced they have successfully shipped in vitro liver models from the UK to a top tier pharma customer in the US. The agreement between the companies combines DefiniGEN’s mechanistically relevant iPSC hepatocytes (Opti-Heps) with Atelerix’s...

Johnson & Johnson have announced it has entered into a definitive agreement with Numab Therapeutics to acquire from Numab’s shareholders its wholly-owned subsidiary for the global rights to NM26, in an all-cash transaction of approximately $1.25 billion....

Owkin has unveiled an innovative drug pipeline in oncology and immunology following an exclusive global licensing agreement with Idorsia to develop and commercialise OKN4395, a clinic-ready best-in-class dual inhibitor of prostanoid receptors EP2 and EP4....

Enzene Biosciences, a leading global CDMO known for its flagship fully-connected continuous manufacturing platform (EnzeneX) have announced the launch of a new Drug Discovery Division. This further expands the CDMOs breadth of services to the...

POA Pharma Scandinavia AB, a speciality pharmaceutical company with expertise across multiple therapeutic areas, has announced the launch of PKU Easy Microtabs Plus in Austria.  This marks the latest milestone for POA Pharma, as...

Kerry Pickstone, Partner at operations transformation consultancy Argon & Co. discusses the impact of the new anti-espionage laws in China, weighing how Western pharmaceutical firms can embed resilience into their supply chain strategies and mitigate...

MSD and Eyebiotech have announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire EyeBio. “We continue to execute on our science-led business development strategy to expand...

Secarna Pharmaceuticals and Orbit Discovery have announced that they have entered into a collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide (ASO) therapeutics. The collaboration will leverage Orbit’s expertise and bead-based peptide display engine...

AGC Biologics and BioConnection, a specialised CMO focusing on aseptic filling of vials and syringes for clinical and commercial production, have announced a new strategic partnership. They are partnering to provide end-to-end biopharmaceutical development and manufacturing...

The European Commission has approved, under EU State aid rules, the first Important Project of Common European Interest to support research, innovation and the first industrial deployment of healthcare products, as well as innovative production...

LabGenius has closed a £35 million Series B financing round. The investment brings LabGenius’ total funding to date to £58 million. The round was led by new investor M Ventures (the strategic, corporate venture capital...

Germfree and Orgenesis Inc. have announced an asset purchase and strategic partnership aimed at advancing Orgenesis’ therapeutic programs and its suite of product development and GMP cell processing services. The collaboration’s goal is to transform the production...

Bio-Sourcing, with partners Ciloa and Intract Pharma, have announced the launch of a €3.4M ($3.7M) EU-funded program, including €1.9M in subsidies from EUREKA Eurostars. The three-year AB-BIOBETTER project aims to develop an oral antibody...

AstraZeneca intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global supply of its ADC portfolio. ADCs are next-generation treatments that deliver highly potent cancer-killing agents directly...

Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patients more efficiently. The three teams will bring together data, software and tuned models...

Aktis Oncology have announced a multi-target discovery collaboration agreement with Eli Lilly and Company to generate anticancer radiopharmaceuticals using Aktis Oncology’s novel miniprotein technology platform. The collaboration draws on Aktis’ proprietary radiopharmaceutical platform together with Lilly’s expertise...

Biogen and Human Immunology Biosciences (HI-Bio) have announced the companies have entered into a definitive agreement under which Biogen has agreed to acquire HI-Bio for $1.15 billion upfront and up to $650 million in potential milestone...

Orna Therapeutics have announced its acquisition of ReNAgade Therapeutics, a pioneer in unlocking the potential of RNA therapeutics that demonstrated industry-leading delivery to multiple extra-hepatic cells in non-human primate (NHP) models over the past 18...

Nona Biosciences have announced that it has entered into a license agreement with AstraZeneca for preclinical monoclonal antibodies that will be used to create targeted therapies in oncology. “We are delighted to announce this agreement with...

SGD Pharma has invested more than €20 million to upgrade its Zhanjiang plant in China. The refurbishment involves a complete rebuild of its furnace and comprehensive improvement of the plant’s facilities. Using the most advanced...

Merck has signed a definitive agreement to acquire life science company Mirus Bio for $600 million. Mirus Bio is a specialist in the development and commercialisation of transfection reagents. Transfection reagents, such as Mirus Bio’s TransIT-VirusGEN, are used...

Serum Institute of India (SII) has announced a strategic investment in IntegriMedical, acquiring a 20% stake in the company, to advance Needle-Free Injection System technology. The partnership between SII and IntegriMedical aligns with SII’s vision...

Johnson & Johnson have announced that it has entered into a definitive agreement to acquire Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, for $850 million in cash, with potential for an...

Serum Institute of India marks a significant milestone with the shipment of its first set of R21/Matrix-M malaria vaccine to Africa. The initial shipment will be sent to the Central African Republic (CAR), followed by other African...

Pharmaceutical packaging is changing, with patient preferences and evolving legislation working in tandem to drive sustainability to the top of the agenda. The need to introduce more environmentally responsible packaging has predominantly been a...

Pheon Therapeutics, a leading Antibody-Drug Conjugate specialist developing next generation ADCs for a wide range of hard-to-treat cancers, have announced the completion of a $120m Series B financing to fund the development of its pipeline of...

Oxford BioDynamics and The London Clinic, one of the UK’s leading private hospitals, have signed an agreement to give The London Clinic patients access to OBD’s EpiSwitch PSE (EpiSwitch Prostate Screening) and EpiSwitch CiRT (Checkpoint...

To discuss the recent news from Exothera that the company are expand into North America, we at EPM caught up with Darren Leva, Chief Business Officer, Exothera.  EPM: Can you explain how Exothera’s expansion of...

Cresset is expanding its existing Asia Pacific presence by creating a new headquarters in Bangalore, one of India’s leading centres for biotechnology and pharmaceutical research.  This latest announcement consolidates Cresset’s position as a global...

UK-based Contract Research Organisation Gentronix has been awarded the King’s Award for Enterprise after achieving a triple-figure revenue growth following rapid expansion in international markets. Gentronix recorded total growth of 239% in overseas earnings over...

Up to now, the sheer amount of work required in bringing intelligent automation systems up to speed and validating them for life sciences R&D purposes, e.g. to transform adverse event case intake, has threatened...

Oxford BioDynamics have announced it is collaborating with the King’s College London team in the immediate follow up of  the APIPPRA trial, the largest RA prevention trial to date. The APIPPRA trial of Abatacept was a...

Johnson & Johnson and Shockwave Medical have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave corresponding to an enterprise value of approximately $13.1 billion including cash acquired. The...

GSK will become the first founding partner of the Fleming Initiative, an innovative and collaborative approach led by Imperial College Healthcare NHS Trust and Imperial College London to tackle antimicrobial resistance (AMR) around the world....

Saint-Gobain Life Sciences has opened a state-of-the-art production facility at Magna Business Park in Citywest. The new facility will enable Saint-Gobain Life Sciences to increase production and further expand its presence in the manufacture and...

Closed Loop Medicine and Pharmanovia have announced the initiation of their OptiZest study, ID: NCT06372470, and first patient recruitment. OptiZest will investigate whether patients with hypertension can improve blood pressure control at home while receiving a personalised...

NeuroSense Therapeutics have announced that it partnered with PhaseV, a pioneer in causal machine learning for clinical trial analysis and optimisation, with respect to the planned Phase 3 trial of PrimeC as a treatment for...

AbbVie and Gilgamesh Pharmaceuticals have announced a collaboration and option-to-license agreement to develop next-generation therapies for psychiatric disorders. This collaboration will leverage AbbVie’s expertise in psychiatry and Gilgamesh’s innovative research platform to discover novel...

Novo Holdings will acquire an approximately 60% controlling stake in Single Use Support, alongside the two company founders who will each retain 10% and Danaher which will retain 20% of the share capital. Founded...

Western blots are frequently included in pharmaceutical research papers to report results when analysing proteins in a sample. However, research shows that Western blot images are a common source of integrity issues, the publication...

Fulcrum Therapeutics have announced that it has entered into a collaboration and license agreement with Sanofi for the development and commercialisation of losmapimod, an oral small molecule being investigated for the treatment of facioscapulohumeral muscular dystrophy...

Entia’s new, home-use, full blood count analyser that provides personalised and preventative care for cancer patients outside of hospital has been approved for use in the UK. The unique analyser is at the heart of...

ArgusEye have announced the close of its funding, raising €2.8 million EUR (~£2.4 million GBP) bringing the total raised by the Company to €3.45 million EUR (~£3 million GPB). The funding was led by Voima...

Ensuring patient adherence to medication is a crucial factor in delivering better health outcomes for patients – but adherence for chronic disease is just 50 per cent globally, leading to significant human and economic...

Regeneron Pharmaceuticals have announced that the investigational gene therapy DB-OTO improved hearing to normal levels in one child (dosed at 11 months of age) within 24 weeks, and initial hearing improvements were observed in a...

Metaphore Biotechnologies have joined Flagship Pioneering in announcing a research collaboration with Novo Nordisk to develop up to two next-generation therapeutics for obesity management. Under the terms of the agreement, Novo Nordisk may pay...

Santander UK has provided Ennogen Healthcare International, a growing UK based pharmaceuticals manufacturer, with a £30 million loan facility to support its international expansion plans. Established in 2011, Ennogen is a pharmaceutical and healthcare...

Ribobay Pharma, a leading Chinese biopharmaceutical CRDMO and a spin-off company of General Biol (Anhui) Co., Ltd, will provide cGMP-level oligonucleotide (oligo) CRDMO services to the world using Cytiva’s first FlexFactory platform for oligo manufacturing. It...

Sanofi’s has entered into a co-exclusive licensing agreement with Novavax, a biotechnology company headquartered in Maryland, US. The terms of the agreement include: a co-exclusive license to co-commercialise Novavax’s current stand-alone adjuvanted COVID-19 vaccine worldwide...

Teva Pharmaceuticals and Medincell have announced results from the efficacy portion of the Phase 3 Subcutaneous OLAnzapine extended-Release Injection Study (SOLARIS) trial evaluating TEV-‘749 in adult patients with schizophrenia compared to placebo. Results demonstrated...

Frank Jäger has been appointed Commercial Director of the newly created CCL Clinical business unit. “The fact that the world’s largest label manufacturer, CCL Label, is setting up a business unit dedicated to the...

Lantern Pharma have announced a strategic AI-driven collaboration with French biotechnology company, Oregon Therapeutics to optimise the development of its first-in-class protein disulfide isomerase (PDI) inhibitor drug candidate XCE853 in novel and targeted cancer indications. Lantern will be leveraging...

Torbay Pharma has boosted its North American growth strategy by bringing on board industry-leading professionals to strengthen its senior leadership team. Accelerated by its recent investment from private equity firm, NorthEdge, the contract manufacturer (CMO)...

Broken String Biosciences have announced it has entered a research collaboration with the Francis Crick Institute, a world-leading biomedical discovery institute dedicated to understanding the biology underlying health and disease. In partnership with leading...

AstraZeneca have announced the successful completion of an equity investment with Cellectis, a clinical-stage biotechnology company. The equity investment and a research collaboration agreement, announced in November 2023 will leverage the Cellectis proprietary gene editing technologies...

Merck is investing more than €300 million in a new research center at its global headquarters in Darmstadt, Germany. In the Advanced Research Center, the Life Science business sector will research solutions for manufacturing...

Bio-Rad Laboratories have announced the launch of three new StarBright Red Dyes — StarBright Red 715, 775, and 815 — and an expansion of its StarBright Violet Dye series with 29 additional highly validated antibodies conjugated...

UV radiation poses a significant threat to our skin, with melanin pigments providing partial protection by absorbing and reflecting incoming radiation. Drawing inspiration from this natural defence, TLX Cargo developed SOLARAP, the next generation...

Production and QC Challenges with mini-tabs The continued growth in demand for mini tablets (micro-tablets or mini-tabs) is hardly surprising given the benefits that they can deliver for healthcare professionals and their patients. Their...

Cormica, has completed the seven-figure purchase of TPM Laboratories (TPM) in New Jersey. Cormica, backed by Limerston Capital, is focused on strategically expanding its capabilities across the U.S and Europe.   TPM is an independent...

AbbVie breaks ground on a new central research building, “LUnA” (LUdwighafens neue Arbeitswelt) and is investing approximately €150 million in its second largest R&D location worldwide. A state-of-the-art research and laboratory building is being...

Bespak and H&T Presspart have announced a collaboration to accelerate the industry’s transition from existing pressurised Metered Dose Inhaler (pMDI) formulations to more climate-friendly alternatives utilising low global warming potential (GWP) propellants. The partnership will...

Novartis has entered into an agreement to acquire Mariana Oncology, a preclinical-stage biotechnology company based in Watertown, Massachusetts focused on developing novel radioligand therapies (RLTs) to treat cancers with high unmet patient need. The...

Neurocrine Biosciences have announced the U.S. FDA has approved INGREZZA SPRINKLE (valbenazine) capsules, a new oral granules formulation of INGREZZA (valbenazine) capsules prescribed for the treatment of adults with tardive dyskinesia and chorea associated with Huntington’s disease. INGREZZA...

Boston Micro Fabrication (BMF) has introduced BMF Biotechnology Inc. Headquartered in San Diego, California, BMF Biotechnology Inc. is dedicated to developing and commercialising innovative BioChips (organ-on-a-chip platforms) through cultivating large-scale tissues in vitro, helping accelerate...

Around 2,000 people attended the 2024 edition of LogiPharma, the annual leading life sciences and supply chain event, making it the largest to date – with 70 percent of exhibition booths already booked for...

Johnson & Johnson have announced it is updating its brand and uniting both its two business segments under the Johnson & Johnson brand name in the UK. The announcement marks the next era for...

ONO Pharmaceutical and Deciphera Pharmaceuticals have entered into a definitive merger agreement under which ONO will acquire all outstanding shares of Deciphera common stock for US $ 25.60 per share in cash through a tender offer...

SynOx Therapeutics have announced it has entered into a $35m loan facility with Hercules Capital. The transaction strengthens the Company’s balance sheet as it executes TANGENT, a registrational Phase 3 study of emactuzumab, SynOx’s potentially...

The pre-filled syringe (PFS) market is growing rapidly, driven by the rising need for innovative biologics and a desire for self-administration treatment options offering greater convenience. This increased demand for PFS is fuelling innovation...

Kühne Holding AG has entered into a definitive agreement to acquire pharma contract development and manufacturing organisation Aenova Group from leading international investment firm BC Partners. As part of the transaction, BC Partners’ advised...

Novartis have announced that the National Institute for Health and Care Excellence has published its Final Draft Guidance (FDG) recommending the combination therapy of dabrafenib with trametinib, within its marketing authorisation, as an option...

Written by: Miroslav Hlaučo, Apheresis Network Manager, SCTbio. In recent years, there have been an increasing number of clinical trials and research projects based on cell technologies that use cells from a patient or healthy...

Owlstone Medical have announced it has secured funding from the Bill & Melinda Gates Foundation. The funding is comprised of a $5 million equity investment to advance Owlstone’s Breath Biopsy platform and $1.5 million in...

Regeneron Pharmaceuticals and Mammoth Biosciences have announced a collaboration to research, develop and commercialise in vivo CRISPR-based gene editing therapies for multiple tissues and cell types.  Regeneron is developing adeno-associated viral vectors (AAVs) using antibody-based targeting to enhance delivery...

Aramex has been awarded the Sustainability in Distribution award at the recent Distributing Pharmaceuticals UK award event at the Coventry Building Society Arena. The awards night recognised the very best in innovation and sustainability...

Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites. Following the opening of its manufacturing facility and...

Novartis have announced that the U.S. Food and Drug Administration (FDA) approved Lutathera (USAN: lutetium Lu 177 dotatate / INN: lutetium (177Lu) oxodotreotide) for the treatment of pediatric patients 12 years and older with somatostatin...

Ascendis Pharma have announced that the United Kingdom’s Medicines & Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for YORVIPATH (palopegteriparatide; developed as TransCon PTH) in Great Britain as a parathyroid hormone (PTH) replacement therapy indicated for...

In our latest Pharma Explained we look explore what Monkeypox is, how it impacts the body, and the larger-scale issues associated with the disease....

Written by: Matthias Mikkelsen, Fill/Finish Systems Specialist, Flexicon Liquid Filling, Watson-Marlow Fluid Technology Solutions. The pharmaceutical sector has always been at the forefront of innovation, and these rapid changes have continued in recent years....

Benchling announced that Zealand Pharma A/S, a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data, collaboration, and insights. Teams across Zealand will...

Bristol Myers Squibb and Cellares have announced a worldwide capacity reservation and supply agreement for the manufacture of CAR T cell therapies in a transaction valued up to $380M in upfront and milestone payments. As part of...

Imugene have announced a strategic manufacturing and process development partnership, which includes the sale of Imugene’s North Carolina Current Good Manufacturing Practice (CGMP) manufacturing facility and the transfer of process and analytical development activities to...

Takeda have announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn’s disease (CD) after induction therapy with intravenous...

Aptamer Group, the developer of novel Optimer binders to enable innovation in the life sciences industry, have announced the progression of a partnership with Kairos Biotech, an early-stage company developing novel therapeutic solutions for transplant rejection....

Roche have announced that the U.S. Food and Drug Administration (FDA) has approved Alecensa (alectinib) for adjuvant treatment following tumour resection for patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) (tumours ≥...

Ferring Pharmaceuticals and SK pharmteco have announced an agreement to scale up commercial manufacturing capacity for the drug substance of Ferring’s intravesical gene therapy Adstiladrin (nadofaragene firadenovec-vncg) for ensuring long-term future supply. Following technology transfer, SK...

GSK have announced that the US Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for its 5-in-1 meningococcal ABCWY (MenABCWY) vaccine candidate. The Prescription Drug User Fee Act (PDUFA)...

In an interview with Jai McIntosh, Editor for EPM, Eric Kaneps, VP, Sales and Marketing at Renaissance Lakewood explores how innovation has been at the heart of the success of the company and the...

Veeva Systems have announced the Veeva AI Partner Program to provide partners with the advanced technology and support needed to integrate Generative AI (GenAI) solutions seamlessly with Veeva Vault applications. “Our customers are exploring GenAI solutions across many use...

Ardena has received Good Manufacturing Practice (GMP) approval from the Dutch Healthcare Authority for its new analytical laboratories in its expanded nanomedicines facility. The facility includes state-of-the-art GMP-compliant cleanrooms to support Ardena’s growing nanomedicines business,...

Recently, the European Medicines Agency (EMA)’s drug safety committee, PRAC, evaluated and analysed the potential risk of side effects in individuals who have used the GLP-1 class of drugs. This follows reports last June...

Across the biopharmaceutical industry, many have expressed concern about the protracted timelines for drug development, which on average are getting longer when most stakeholders insist the time to market (TTM) needs to be shorter....

On April 15th, Novartis presented results from a pre-specified interim analysis of the Phase III APPLAUSE-IgAN study of Fabhalta (iptacopan), an investigational Factor B inhibitor of the alternative complement pathway, in patients with IgA nephropathy...

MSD has launched the first all-in-one, validated genetic stability assay of its kind. The Aptegra CHO genetic stability assay leverages whole genome sequencing and bioinformatics to significantly accelerate biosafety testing for clients and therefore, their move...

Investing in life science companies is both challenging and rewarding. The sector is constantly evolving and comes with a lot of unknowns and risks, especially at the commercialisation stage. However, with the potential to...

SK Life Science, a subsidiary of SK Biopharmaceuticals, have announced that the U.S. Food and Drug Administration (FDA) approved two new administration options of XCOPRI (cenobamate tablets) CV, an antiseizure medication (ASM) for adults with...

Lonza has had a busy opening to 2024, most notably the company announced that it has had a $1.2b offer accepted by Roche Pharmaceuticals to acquire the Genentech large-scale biologics manufacturing site in Vacaville,...

Oligonucleotide therapies offer a targeted approach to modulating gene expression, splicing, and protein production. By selectively manipulating specific molecular processes, these therapies hold the potential to treat a wide range of diseases (e.g., genetic...

Serum Institute of India (SII), the world’s largest vaccine manufacturer, has joined forces with Univercells, a Belgian biotech innovator, targeting a dramatic increase in accessibility to personalised cancer care. This partnership aims to bring...